logo
School of Pharmacy
   
   
  

Division of Medicinal Chemistry and Structural Biology - Industry-related Research

Head of Division - Professor Peter Fischer

Based in the Centre for Biomolecular Sciences

This table shows the areas of expertise and techniques available in the Division of Medicinal Chemistry and Strucural Biology

  • Search our capabilities by entering a keyword in the ‘Filter’ box
  • You can contact our academic staff to discuss opportunities to collaborate using the links below
  • Return to the full searchable table (with all 5 Divisions) by following this link
  • For further information about Medicinal Chemistry and Structural Biology please see the Division’s website

 

Keyword(s) Area of Expertise or Technique available Academic Contact
Drug Discovery Drug discovery and medicinal chemistry in the areas of oncology, cardiovascular disease, infection & immunity, respiratory disease, inflammation, neurodegenerative disease Peter Fischer
Medicinal Chemistry Drug discovery and medicinal chemistry in the areas of oncology, cardiovascular disease, infection & immunity, respiratory disease, inflammation, neurodegenerative disease Peter Fischer
High throughput compound screening High throughput compound screening: fully automated state-of-the-art facility for a managed compound collection (initially >100k diverse drug-like small molecules) currently being established

Peter Fischer

Computational Methods High performance computational methods for molecular modelling, nanomedicine and drug design Charles Laughton
High performance computing Computational methods for molecular modelling, nanomedicine and drug design Charles Laughton
Molecular modelling Computational methods for molecular modelling, nanomedicine and drug design Charles Laughton
Structure-based ligand design Active Site Pressurisation (ASP): a new structure-based ligand design that takes into account target protein Charles Laughton
Drug design Computational methods for molecular modelling, nanomedicine and drug design Charles Laughton
Protein-protein interactions Characterisation of protein-protein and protein-ligand interactions. LXXLL and related motifs. Lodewijk Dekker , Stephanie Allen , David Heery
Protein-ligand interactions Characterisation of protein-protein and protein-ligand interactions. LXXLL and related motifs. Lodewijk DekkerStephanie Allen , David Heery
Enzymes Mechanism of enzymatic reactions, using X-ray crystallographyMechanism of enzymatic reactions, using X-ray crystallography Jonas Emsley
Fluorescent ligand design Fluorescent ligand design Barrie Kellam
Peptides Chemistry of peptides and peptidomimetics Weng Chan
Peptidomimetics Chemistry of peptides and peptidomimetics Weng Chan
Protein Structure Protein structure determination by X-ray crystallography Jonas Emsley
X-ray crystallography Protein structure determination by X-ray crystallography Jonas Emsley
High throughput crystallisation robotics High throughput crystallisation robotics for X-ray diffraction studies Jonas Emsley
Fluorescent assay technology Fluorescent assay technology Barrie Kellam
NMR spectroscopy NMR spectroscopy Lee Hibbett
Mass spectrometry (including LC-MS-MS) Mass spectrometry (including LC-MS-MS) Lee Hibbett
High pressure liquid chromatography High pressure liquid chromatography Lee Hibbett
 

Contact

Dr Mark Gilbert
Business Development Officer
mark.gilbert@nottingham.ac.uk
Tel: +44 (0)115 846 8469

School of Pharmacy

University of Nottingham
University Park
Nottingham, NG7 2RD

telephone: +44 (0) 115 951 5100
fax: +44 (0) 115 951 5102
email: pharmacy-enquiries@nottingham.ac.uk